The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context.
The COPD Foundation is kicking off its 20th anniversary year with exciting news! Bronchiectasis and NTM 360, a division of the COPD Foundation, is thrilled to announce its journey to establish a Bronchiectasis and NTM Care Center Network.
The treatable traits approach represents a strategy for patient management. It is based on the identification of characteristics susceptible to treatments or predictive of treatment response in each individual patient.
El neumólogo e investigador de Barcelona Respiratory Network pide realizar este tipo de pruebas para detectar precozmente esta patología
Since 2001 the GOLD publishes and updates every year a document that recommends how to best diagnose and manage COPD. The GOLD 2024 document has just been released and is available for free download in the GOLD website.
The GOLD 2023 report identifies different causes (etiotypes) of COPD. Their prevalence in individuals in the general population with persistent airflow obstruction (PAO) is unknown.
«Biologics for COPD — Finally Here» highlighted as one of the notable articles among the featured selections on NEJM Notable Articles of 2023
Chronic obstructive pulmonary disease (COPD) is a major public health problem that remains largely neglected.
Vídeo de la Presentación de las Novedades Gold 2024 del 21 de Noviembre de 2023, de 17 a 19h.
The 2023 theme for World COPD Day was “Breathing is Life – Act Earlier» and took place on November 15th. This year’s theme aimed to highlight the importance of early lung health, early diagnosis and early interventions.
